Virta Health is transforming type 2 diabetes treatment through its virtual care platform that helps patients reverse the disease without medications or surgery. By combining personalized nutrition therapy, 24/7 access to providers via its mobile app, and continuous remote monitoring, Virta delivers sustainable diabetes reversal. The company now works with over 200 enterprise customers, including employers, health plans, and government organizations.
Virta was co-founded in 2014 by Sami Inkinen, previously co-founder of real estate marketplace Trulia, and doctors Stephen Phinney and Jeff Volek, renowned experts in low-carb nutrition and metabolic health. Fresh off a $133 million Series E round that valued the company at $2 billion, Virta plans to accelerate growth to meet surging demand for its clinically-proven diabetes reversal treatment.
At Virta, employees have the opportunity to work on the frontlines of the metabolic health crisis alongside top scientists, technologists, and clinicians. With its contrarian non-pharmaceutical approach, Virta aims to reverse diabetes in 100 million people by 2025.
2014
Founded
250-500
Employees
Series E
Stage
>$2B
Latest Valuation
$200-400M
Total Funding
Apr 19 2021
Last Fundraise
Why is the rating
Top Previous Employers

Castlight Health

DaVita Kidney Care


Noom

University of California, Berkeley
Investors

Founders Fund
Facebook, SpaceX, Affirm

Sequoia Capital
WhatsApp, Zoom, Apple